Annual Retained Earnings
$1.50 B
+$2.08 B+361.67%
31 December 2023
Summary:
AstraZeneca annual retained earnings is currently $1.50 billion, with the most recent change of +$2.08 billion (+361.67%) on 31 December 2023. During the last 3 years, it has fallen by -$3.80 billion (-71.66%). AZN annual retained earnings is now -91.78% below its all-time high of $18.27 billion, reached on 31 December 2010.AZN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$3.14 B
+$1.29 B+69.90%
30 September 2024
Summary:
AstraZeneca quarterly retained earnings is currently $3.14 billion, with the most recent change of +$1.29 billion (+69.90%) on 30 September 2024. Over the past year, it has increased by +$3.57 billion (+823.04%). AZN quarterly retained earnings is now -83.14% below its all-time high of $18.61 billion, reached on 30 September 2011.AZN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +361.7% | +823.0% |
| 3 y3 years | -71.7% | +42.6% |
| 5 y5 years | -73.6% | +68.3% |
AZN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -71.7% | +361.7% | at high | +227.0% |
| 5 y | 5 years | -73.6% | +361.7% | -41.2% | +227.0% |
| alltime | all time | -91.8% | +361.7% | -83.1% | +227.0% |
AstraZeneca Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.14 B(+69.9%) |
| June 2024 | - | $1.85 B(-971.2%) |
| Mar 2024 | - | -$212.00 M(-114.1%) |
| Dec 2023 | $1.50 B(-361.7%) | $1.50 B(-446.1%) |
| Sept 2023 | - | -$434.00 M(+85.5%) |
| June 2023 | - | -$234.00 M(-87.2%) |
| Mar 2023 | - | -$1.82 B(+217.9%) |
| Dec 2022 | -$574.00 M(-133.6%) | -$574.00 M(-76.8%) |
| Sept 2022 | - | -$2.47 B(+49.1%) |
| June 2022 | - | -$1.66 B(+34.9%) |
| Mar 2022 | - | -$1.23 B(-171.8%) |
| Dec 2021 | $1.71 B(-67.7%) | $1.71 B(-22.3%) |
| Sept 2021 | - | $2.20 B(-58.8%) |
| June 2021 | - | $5.33 B(+30.5%) |
| Mar 2021 | - | $4.09 B(-22.8%) |
| Dec 2020 | $5.30 B(+88.4%) | $5.30 B(+182.5%) |
| Sept 2020 | - | $1.88 B(-1.9%) |
| June 2020 | - | $1.91 B(+327.0%) |
| Mar 2020 | - | $448.00 M(-84.1%) |
| Dec 2019 | $2.81 B(-50.5%) | $2.81 B(+50.8%) |
| Sept 2019 | - | $1.86 B(-42.9%) |
| June 2019 | - | $3.27 B(-11.3%) |
| Mar 2019 | - | $3.68 B(-35.2%) |
| Dec 2018 | $5.68 B(-30.9%) | $5.68 B(+10.1%) |
| Sept 2018 | - | $5.16 B(-12.2%) |
| June 2018 | - | $5.88 B(-4.6%) |
| Mar 2018 | - | $6.16 B(-25.0%) |
| Dec 2017 | $8.22 B(+1.0%) | $8.22 B(+17.4%) |
| Sept 2017 | - | $7.00 B(+1.0%) |
| June 2017 | - | $6.93 B(+10.6%) |
| Mar 2017 | - | $6.26 B(-23.1%) |
| Dec 2016 | $8.14 B(-31.2%) | $8.14 B(+27.6%) |
| Sept 2016 | - | $6.38 B(-7.0%) |
| June 2016 | - | $6.86 B(-15.1%) |
| Mar 2016 | - | $8.07 B(-31.8%) |
| Dec 2015 | $11.83 B(-9.2%) | $11.83 B(+10.5%) |
| Sept 2015 | - | $10.71 B(-8.1%) |
| June 2015 | - | $11.65 B(+13.0%) |
| Mar 2015 | - | $10.30 B(-20.9%) |
| Dec 2014 | $13.03 B(-23.2%) | $13.03 B(-6.2%) |
| Sept 2014 | - | $13.89 B(-10.4%) |
| June 2014 | - | $15.50 B(+3.4%) |
| Mar 2014 | - | $14.99 B(-11.6%) |
| Dec 2013 | $16.96 B(-5.5%) | $16.96 B(-1.4%) |
| Sept 2013 | - | $17.20 B(+0.1%) |
| June 2013 | - | $17.18 B(+5.0%) |
| Mar 2013 | - | $16.37 B(-8.8%) |
| Dec 2012 | $17.95 B | $17.95 B(+9.9%) |
| Sept 2012 | - | $16.33 B(-0.5%) |
| June 2012 | - | $16.41 B(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $16.03 B(-10.4%) |
| Dec 2011 | $17.89 B(-2.1%) | $17.89 B(-3.9%) |
| Sept 2011 | - | $18.61 B(+1.5%) |
| June 2011 | - | $18.34 B(+5.8%) |
| Mar 2011 | - | $17.33 B(-5.1%) |
| Dec 2010 | $18.27 B(+12.8%) | $18.27 B(+6.0%) |
| Sept 2010 | - | $17.23 B(-1.1%) |
| June 2010 | - | $17.42 B(+8.0%) |
| Mar 2010 | - | $16.14 B(-0.4%) |
| Dec 2009 | $16.20 B(+40.0%) | $16.20 B(+8.1%) |
| Sept 2009 | - | $14.99 B(+11.5%) |
| June 2009 | - | $13.44 B(+21.9%) |
| Mar 2009 | - | $11.02 B(-4.8%) |
| Dec 2008 | $11.57 B(+8.9%) | $11.57 B(-2.1%) |
| Sept 2008 | - | $11.82 B(+0.2%) |
| June 2008 | - | $11.80 B(+11.5%) |
| Mar 2008 | - | $10.59 B(-0.4%) |
| Dec 2007 | $10.62 B(-6.4%) | $10.62 B(+1.1%) |
| Sept 2007 | - | $10.51 B(-2.4%) |
| June 2007 | - | $10.76 B(+8.3%) |
| Mar 2007 | - | $9.94 B(-12.4%) |
| Dec 2006 | $11.35 B(+6.3%) | $11.35 B(+4.9%) |
| Sept 2006 | - | $10.82 B(-3.7%) |
| June 2006 | - | $11.23 B(-1.0%) |
| Mar 2006 | - | $11.35 B(+6.3%) |
| Dec 2005 | $10.68 B(-7.9%) | $10.68 B(+3.0%) |
| Sept 2005 | - | $10.37 B(-2.1%) |
| June 2005 | - | $10.60 B(-0.8%) |
| Mar 2005 | - | $10.68 B(-7.9%) |
| Dec 2004 | $11.59 B(+10.9%) | $11.59 B(+11.0%) |
| Sept 2004 | - | $10.44 B(+5.6%) |
| June 2004 | - | $9.89 B(+3.5%) |
| Mar 2004 | - | $9.56 B(-8.5%) |
| Dec 2003 | $10.45 B(+23.6%) | $10.45 B(+23.6%) |
| Dec 2002 | $8.45 B(+22.4%) | $8.45 B(+22.4%) |
| Dec 2001 | $6.90 B(-0.8%) | $6.90 B(-0.8%) |
| Dec 2000 | $6.96 B(-18.5%) | $6.96 B(-18.5%) |
| Dec 1999 | $8.54 B(+599.8%) | $8.54 B(+235.7%) |
| Sept 1999 | - | $2.54 B(+499.8%) |
| June 1999 | - | $424.00 M(-65.2%) |
| Dec 1998 | $1.22 B(-50.2%) | $1.22 B(-57.8%) |
| June 1998 | - | $2.89 B(+18.0%) |
| Dec 1997 | $2.45 B(+18.4%) | $2.45 B(+18.4%) |
| Dec 1996 | $2.07 B(+25.5%) | $2.07 B(+25.5%) |
| Dec 1995 | $1.65 B(+10.3%) | $1.65 B(-17.0%) |
| June 1995 | - | $1.99 B(+32.9%) |
| Dec 1994 | $1.49 B(+25.2%) | $1.49 B(+25.2%) |
| Dec 1993 | $1.19 B(-4.8%) | $1.19 B |
| Dec 1992 | $1.25 B(+60.4%) | - |
| Dec 1991 | $782.16 M(+37.0%) | - |
| Dec 1990 | $570.97 M | - |
FAQ
- What is AstraZeneca annual retained earnings?
- What is the all time high annual retained earnings for AstraZeneca?
- What is AstraZeneca annual retained earnings year-on-year change?
- What is AstraZeneca quarterly retained earnings?
- What is the all time high quarterly retained earnings for AstraZeneca?
- What is AstraZeneca quarterly retained earnings year-on-year change?
What is AstraZeneca annual retained earnings?
The current annual retained earnings of AZN is $1.50 B
What is the all time high annual retained earnings for AstraZeneca?
AstraZeneca all-time high annual retained earnings is $18.27 B
What is AstraZeneca annual retained earnings year-on-year change?
Over the past year, AZN annual retained earnings has changed by +$2.08 B (+361.67%)
What is AstraZeneca quarterly retained earnings?
The current quarterly retained earnings of AZN is $3.14 B
What is the all time high quarterly retained earnings for AstraZeneca?
AstraZeneca all-time high quarterly retained earnings is $18.61 B
What is AstraZeneca quarterly retained earnings year-on-year change?
Over the past year, AZN quarterly retained earnings has changed by +$3.57 B (+823.04%)